Bryon L. Simmons;Feng Xu;Jerry A. Murry;Daniel J. Kumke
发明人:
Daniel J. Kumke,Jerry A. Murry,Bryon L. Simmons,Feng Xu
申请号：
US13210908
公开号：
US08193216B2
申请日:
2011.08.16
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention is directed to novel polymorphic forms of the compound 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol hydrate (gaboxadol monohydrate). The invention is further concerned with pharmaceutical compositions containing the polymorphic forms as an active ingredient, methods for treatment of disorders susceptible to amelioration by GABAA receptor agonism with the polymorphic forms, and processes for the preparation of the polymorphic forms.
